Bioresponsive MR Imaging Probes for Noninvasive Monitoring of AAV Gene Therapy
Bioconjugate Chemistry · 2026
DOI: 10.1021/acs.bioconjchem.5c00525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Jian-Hong Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Chemistry, Molecular Biosciences, Neurobiology, and Radiology, Northwestern University, Evanston, Illinois 60208, United States. Hauptthemen laut MEDLINE: Dependovirus, Magnetic Resonance Imaging, Genetic Therapy, Contrast Media. Die Arbeit nennt 34 Literaturangaben. Gefördert von: NINDS NIH HHS, NCI NIH HHS, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Gene therapy has emerged as a powerful approach for treating diverse diseases, including genetic disorders, retinal diseases, and certain cancers. Real-time, noninvasive in vivo tracking of gene expression is essential for evaluating therapeutic efficacy. β-galactosidase (β-gal), a hydrolase encoded by the Escherichia coli lacZ gene or the human GLB1 gene, is widely used as a reporter of gene expression. In humans, β-gal deficiency underlies several fatal neurodegenerative disorders, including GM1 gangliosidosis. Here, we report the development of a β-gal–activated, human serum albumin (HSA)-binding gadolinium(III)-based MR contrast agent for noninvasive assessment of adeno-associated virus (AAV) gene therapy in GM1 gangliosidosis mice. The probe exhibited a gradual increase in MR relaxation rate upon incubation with β-gal in the presence of 4.5% HSA. Following intravenous administration, AAV-treated GM1 mice demonstrated distinct MR signal enhancement and kinetic profiles compared to untreated β-gal–deficient controls. This study establishes an enzyme-activated, protein-binding MR imaging strategy for real-time, noninvasive monitoring of AAV gene therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Chemistry, Molecular Biosciences, Neurobiology, and Radiology, Northwestern University, Evanston, Illinois 60208, United States.
- Horae Gene Therapy Center, Department of Radiology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, United States.
- Department of Chemistry and Magnetic Resonance Center (CERM), University of Florence, and Consorzio Interuniversitario Risonanze Magnetiche Metallo Proteine (CIRMMP), Via L. Sacconi 6, 50019 Sesto Fiorentino, Italy.
ORCID-Profile: Jian-Hong Tang, Srinivasan Jayakumar, Giacomo Parigi, Thomas J Meade
Förderung
- NINDS NIH HHS
- NCI NIH HHS
- National Institute of Neurological Disorders and Stroke
- Ministero dell'Universit? e della Ricerca
Zitieren
APA
Tang, J. H., Taghian, T., Jayakumar, S., Parigi, G., Luchinat, C., Hall, E., Gray-Edwards, H. L., & Meade, T. J. (2026). Bioresponsive MR Imaging Probes for Noninvasive Monitoring of AAV Gene Therapy. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.5c00525
Vancouver
Tang JH, Taghian T, Jayakumar S, Parigi G, Luchinat C, Hall E, et al. Bioresponsive MR Imaging Probes for Noninvasive Monitoring of AAV Gene Therapy. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.5c00525
BibTeX
@article{Tang2026,
author = {Tang, Jian-Hong and Taghian, Toloo and Jayakumar, Srinivasan and Parigi, Giacomo and Luchinat, Claudio and Hall, Erin and Gray-Edwards, Heather L and Meade, Thomas J},
title = {Bioresponsive MR Imaging Probes for Noninvasive Monitoring of AAV Gene Therapy},
journal = {Bioconjugate Chemistry},
year = {2026},
doi = {10.1021/acs.bioconjchem.5c00525}
}
EUVIMED